Selected Problems of Infancy and Childhood

  • Sanford R. Kimmel
  • John Chessare

Abstract

The interactional model of human development recognizes that each child has a genetic potential that is shaped through life experiences.1 Central nervous system (CNS) attributes are inherited, but a warm, nurturing, and loving environment is necessary for the individual to reach his or her maximum fulfillment. It is the role of the family physician to follow the neurodevelopment of the child from infancy into adulthood and to identify significant deviations from the norm. The interactional model allows consideration of biologic and psychosocial factors in the etiology of abnormal development (Table 17.1).

Keywords

Dust Gasoline Sponge Radon Glaucoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thomas A, Chess S. Dynamics of psychological development. New York: Brunner-Mazel, 1980.Google Scholar
  2. 2.
    Thomas A, Chess S. Temperament and development. New York: Brunner-Mazel, 1977.Google Scholar
  3. 3.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington, DC: APA, 1987:50–52.Google Scholar
  4. 4.
    Conners CK. A teacher rating scale for use in drug studies with children. Am J Psychiatry 1969;126:884–8.PubMedGoogle Scholar
  5. 5.
    Mayer JL, Balk SJ. A tip-toe through the toxins. Contemp Pediatr 1988;5:22–40.Google Scholar
  6. 6.
    Haddow JE, Knight GJ, Palomaki GE, Kloza EM, Wald NJ. Cigarette consumption and serum continine in relation to birthweight. Br J Obstet Gynaecol 1987;94:678–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Centers for Disease Control. Preventing lead poisoning in young children: a statement by the Centers for Disease Control. Atlanta: CDC, 1991:1–105.Google Scholar
  8. 8.
    Shannon MW, Graef JW. Lead intoxication in infancy. Pediatrics 1992;89:87–90.PubMedGoogle Scholar
  9. 9.
    Centers for Disease Control. Childhood lead poisoning—United States: report to the Congress by the Agency for Toxic Substances and Disease Registry. MMWR 1988;37:481–5.Google Scholar
  10. 10.
    Amitai Y, Brown MJ, Graef JW, Cosgrove E. Residential delead-ing: effects on the blood lead levels for lead-poisoned children. Pediatrics 1991;88:893–7.PubMedGoogle Scholar
  11. 11.
    Austin G. Lead paint: encapsulation with a new product might render the hazard harmless. Toledo Blade Jan. 26, 1992; Sect. C:l(col. 2–6).Google Scholar
  12. 12.
    Glotzer DE, Bauchner H. Management of childhood lead poisoning: a survey. Pediatrics 1992;89:614–18.PubMedGoogle Scholar
  13. 13.
    Centers for Disease Control, Center for Environmental Health and Injury Control, Division of Injury Control. Childhood injuries in the United States. Am J Dis Child 1990;144:627–46.Google Scholar
  14. 14.
    Greensher J. Recent advances in injury prevention. Pediatr Rev 1988;10:171–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Strasburger VC. Children, adolescents, and television. Pediatr Rev 1992;13:144–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Glotzer D. Weitzman M. Childhood injuries: issues for the family physician. Am Fam Physician 1991;44:1705–16.PubMedGoogle Scholar
  17. 17.
    Rushton HG. Nocturnal enuresis: epidemiology, evaluation, and currently available treatment options. J Pediatr 1989;114:691–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Warady BA, Alon U, Hellerstein S. Primary nocturnal enuresis: current concepts about an old problem. Pediatr Ann 1991 ;20:246–55.PubMedGoogle Scholar
  19. 19.
    Moffatt MEK. Nocturnal enuresis: psychologic implications of treatment and nontreatment. J Pediatr 1989;114:697–704.PubMedCrossRefGoogle Scholar
  20. 20.
    Novello AC, Novello JR. Enuresis. Pediatr Clin North Am 1987; 34:719–33.Google Scholar
  21. 21.
    Himsl KK, Hurwitz RS. Pediatric urinary incontinence. Urol Clin North Am 1991;18:283–93.PubMedGoogle Scholar
  22. 22.
    N0rgaard JP, Rettig S, Djurhuus JC. Nocturnal enuresis: an approach to treatment based on pathogenesis. J Pediatr 1989;114: 705–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Klauber GT. Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis. J Pediatr 1989;114:719–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Cooley WC, Graham JM. Common syndromes and management issues for primary physicians: Down syndrome—an update and review for the primary pediatrician. Clin Pediatr 1991;30:233–53.Google Scholar
  25. 25.
    Pueschel SM. Clinical aspects of Down syndrome from infancy to adulthood. Am J Med Genet Suppl 1990;7:52–56.PubMedGoogle Scholar
  26. 26.
    Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988;81:102–10.PubMedGoogle Scholar
  27. 27.
    Zigler E, Hodapp RM. Behavioral functioning in individuals with mental retardation. Annu Rev Psychol 1991;42:29–50.PubMedCrossRefGoogle Scholar
  28. 28.
    Elkins TE. Reproductive health concerns of the person with Down syndrome. J Pediatr Neurosci 1987;3:28–36.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Sanford R. Kimmel
  • John Chessare

There are no affiliations available

Personalised recommendations